• A COVID19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus...
    192 KB (22,021 words) - 06:25, 3 May 2024
  • Thumbnail for Moderna COVID-19 vaccine
    The Moderna COVID19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by the American company Moderna, the United States National...
    165 KB (13,017 words) - 17:59, 27 April 2024
  • Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
    236 KB (19,394 words) - 05:58, 20 April 2024
  • Thumbnail for Oxford–AstraZeneca COVID-19 vaccine
    Oxford–AstraZeneca COVID19 vaccine, sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for the prevention of COVID-19. It was...
    211 KB (16,862 words) - 03:56, 2 May 2024
  • Thumbnail for Novavax COVID-19 vaccine
    The Novavax COVID-19 vaccine, sold under the brand names Nuvaxovid and Covovax, among others, is a subunit COVID-19 vaccine developed by Novavax and the...
    71 KB (5,359 words) - 07:41, 1 May 2024
  • Thumbnail for Deployment of COVID-19 vaccines
    53 billion COVID-19 vaccine doses have been administered worldwide, with 70.6 percent of the global population having received at least one dose. While 4.19 million...
    156 KB (13,920 words) - 06:50, 28 March 2024
  • Thumbnail for Janssen COVID-19 vaccine
    The Janssen COVID19 vaccine, sold under the brand name Jcovden, is a COVID19 vaccine that was developed by Janssen Vaccines in Leiden, Netherlands,...
    142 KB (11,316 words) - 14:22, 4 February 2024
  • authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines. Ten vaccines have been approved for emergency or full use by at least one...
    318 KB (19,351 words) - 20:00, 21 April 2024
  • Thumbnail for COVID-19 vaccine misinformation and hesitancy
    variety of unfounded conspiracy theories and other misinformation about COVID-19 vaccines have spread based on misunderstood or misrepresented science, religion...
    129 KB (12,583 words) - 03:43, 27 April 2024
  • Thumbnail for History of COVID-19 vaccine development
    an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration...
    122 KB (11,028 words) - 02:32, 27 January 2024
  • Thumbnail for Sputnik V COVID-19 vaccine
    Gam-COVID-Vac (Russian: Гам-КОВИД-Вак, the name under which it is legally registered and produced) is an adenovirus viral vector vaccine for COVID-19 developed...
    154 KB (13,880 words) - 13:52, 20 April 2024
  • Thumbnail for Sinopharm BIBP COVID-19 vaccine
    COVID-19 vaccine, also known as BBIBP-CorV, the Sinopharm COVID-19 vaccine, or BIBP vaccine, is one of two whole inactivated virus COVID-19 vaccines developed...
    90 KB (8,570 words) - 16:40, 27 January 2024
  • Thumbnail for COVID-19 vaccine card
    A COVID-19 vaccine card is a record often given to those who have received a COVID-19 vaccine showing information such as the date(s) one has received...
    38 KB (3,775 words) - 15:33, 2 May 2024
  • Thumbnail for COVID-19
    isothermal amplification (RT‑LAMP) from a nasopharyngeal swab. Several COVID-19 vaccines have been approved and distributed in various countries, many of which...
    285 KB (32,672 words) - 14:17, 28 April 2024
  • Thumbnail for MVC COVID-19 vaccine
    MVC-COV1901 and also known as the Medigen COVID-19 vaccine, is a protein subunit COVID-19 vaccine developed by Medigen Vaccine Biologics Corporation in Taiwan,...
    15 KB (1,455 words) - 14:15, 9 March 2024
  • Thumbnail for Valneva COVID-19 vaccine
    Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical...
    18 KB (1,318 words) - 13:22, 28 March 2024
  • Thumbnail for MRNA vaccine
    vaccines, such as the Pfizer–BioNTech COVID-19 vaccine, have the disadvantage of requiring ultracold storage before distribution, other mRNA vaccines...
    78 KB (7,926 words) - 15:19, 26 April 2024
  • Thumbnail for Sanofi–GSK COVID-19 vaccine
    Sanofi–GSK COVID-19 vaccine sold under the brand name VidPrevtyn Beta, is a COVID-19 vaccine developed by Sanofi Pasteur and GSK. The Sanofi–GSK COVID19 vaccine...
    18 KB (1,385 words) - 20:42, 22 January 2024
  • Thumbnail for Vaxart COVID-19 vaccine
    Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of...
    2 KB (98 words) - 04:31, 28 August 2023
  • Thumbnail for Stemirna COVID-19 vaccine
    Stemirna COVID-19 vaccine is a COVID-19 vaccine candidate developed by Stemirna Therapeutics. "Randomized, double-blind, placebo-controlled phase I clinical...
    3 KB (103 words) - 03:06, 12 October 2023
  • Thumbnail for COVID-19 vaccination in the United States
    public–private partnership to expedite the development and manufacturing of COVID-19 vaccines. Joe Biden became the new President of the United States on January...
    134 KB (2,167 words) - 14:50, 21 March 2024
  • Thumbnail for COVID-19 vaccination in the United Kingdom
    Pfizer–BioNTech COVID-19 vaccine. There are three vaccines currently in use; following approval of the Pfizer–BioNTech COVID-19 vaccine (Comirnaty), vaccines developed...
    99 KB (8,236 words) - 05:40, 15 April 2024
  • Thumbnail for CoronaVac
    CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech...
    120 KB (11,030 words) - 21:48, 14 April 2024
  • Thumbnail for COVID-19 vaccine clinical research
    COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy...
    98 KB (20,593 words) - 02:58, 8 March 2024
  • Thumbnail for Vaccine passports during the COVID-19 pandemic
    and jurisdictions as part of efforts to control the COVID-19 pandemic via vaccination. A vaccine passport is typically issued by a government or health...
    92 KB (8,788 words) - 17:57, 13 January 2024
  • Sinopharm COVID-19 vaccine may refer to: Sinopharm BIBP COVID-19 vaccine Sinopharm CNBG COVID-19 vaccine Sinopharm WIBP COVID-19 vaccine This disambiguation...
    217 bytes (56 words) - 12:06, 2 November 2022
  • Thumbnail for Walvax COVID-19 vaccine
    originally termed ARCoV and also known as the Walvax COVID-19 vaccine, is an mRNA COVID-19 vaccine developed by Walvax Biotechnology, Suzhou Abogen Biosciences...
    14 KB (1,441 words) - 21:06, 14 October 2023
  • Thumbnail for COVID-19 pandemic in the United States
    2021. COVID-19 vaccines became available in December 2020, under emergency use, beginning the national vaccination program, with the first vaccine officially...
    172 KB (19,577 words) - 15:10, 24 April 2024
  • Thumbnail for Inovio COVID-19 vaccine
    Inovio COVID-19 vaccine is a COVID-19 vaccine candidate developed by Inovio Pharmaceuticals. In February 2020 after receiving details of the genetic sequence...
    9 KB (878 words) - 12:14, 6 March 2024
  • Thumbnail for Vabiotech COVID-19 vaccine
    Vabiotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by the Vaccine and Biological Production Company No. 1 (Vabiotech) in Vietnam. In...
    7 KB (668 words) - 20:53, 27 September 2023